Product Information
BUMETANIDE 0.5 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1356 per EA under NDC 51672422301. Its NADAC has been published 126 times since Jan 31, 2024.
Strength
.5 mg/1
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672422301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213458On Market Since
7/24/2023
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 0.5 MG TABLET has been published 126 times since Jan 31, 2024, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.2136 (Mar 13, 2024) |
| All-time low | $0.1213 (May 22, 2024) |
| 52-week high | $0.1658 |
| 52-week low | $0.1265 |
| Median price | $0.1433 |
| Average price | $0.1502 |
| Largest weekly change | +29.3% (Jun 19, 2024) |
| Weeks tracked | 126 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUMETANIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 0.5 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1356 per EA (NDC 51672422301), effective Jun 24, 2026.
How has the price of BUMETANIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 0.5 MG TABLET has declined 30.4%. It has been tracked across 126 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 0.5 MG TABLET?
Since Jan 31, 2024, the NADAC for BUMETANIDE 0.5 MG TABLET has ranged from a low of $0.1213 (May 22, 2024) to a high of $0.2136 (Mar 13, 2024), with a median of $0.1433 per EA.
Are there cheaper alternatives to BUMETANIDE 0.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as BUMETANIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures BUMETANIDE 0.5 MG TABLET?
BUMETANIDE 0.5 MG TABLET (NDC 51672422301) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification